Controlled Chaos

Controlled Chaos

Here is what we know so far, Johnson and Johnson (NYSE: JNJ) has decided to go home; Tandem (NASDAQ: TNDM) is getting ready to say goodbye which leaves Insulet (NASDAQ: PODD) as the last insulin pump company to announce their intentions. Now we don’t expect Insulet to go anywhere anytime soon. The question is will they benefit from the free for all that is about to take place in the insulin pump market or will Medtronic (NYSE: MDT) just add to their already sizable share advantage . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.